Skip to content

Inter-individual Variation in the Blood Pressure Lowering Effects of Dietary Nitrate

Effects of Dietary Nitrate on Blood Pressure: Exploring the Repeatability and Inter-individual Variation in Responses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05514821
Enrollment
15
Registered
2022-08-24
Start date
2022-10-15
Completion date
2023-09-25
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

Hypertension, Personalized nutrition, Nitric oxide, Beetroot juice

Brief summary

Dietary nitrate supplementation, often in the form of beetroot juice, has been shown to lower blood pressure and could play a role in preventing or treating hypertension. However, it is currently unclear: a) how reproducible this response is within the same individual on different occasions, and b) whether there are genuine individual differences in the blood pressure lowering effects of dietary nitrate. This study will use a novel replicated cross-over design (2 x nitrate conditions, 2 x placebo conditions) to examine the reproducibility and inter-individual variability in the blood pressure lowering effects of dietary nitrate supplementation.

Detailed description

The investigators will undertake a replicated cross-over randomised controlled trial (i.e., a study involving 2 x identical experimental conditions and 2 x identical control conditions), to explore the reproducibility of the blood pressure lowering effects of nitrate-rich beetroot juice, and to identify if there are genuine individual differences in the blood pressure-lowering effects of this supplement. Participants will be recruited via posters, email and social media, and interested individuals will be invited to attend the laboratory on 5 occasions. Visit 1: Potential participants will be invited to attend a screening session at Newcastle University to identify if they are eligible to participate. They will have an opportunity to discuss the study with a researcher and will provide written consent. They will then complete a screening questionnaire and provide a measure of their height, weight and blood pressure. Eligible participants will be invited to attend 4 experimental trials (2 x nitrate-rich beetroot juice conditions, 2 x placebo conditions) over 2-3 weeks with a minimum of 3 days wash-out between visits. If individuals are ineligible to participate this will be explained to them and they will be thanked for their time. Visits 2-5: On the day before the first trial, participants will be asked to record what they eat and then replicate this as closely as possible for all future visits. In the morning of each trial, participants will be asked to arrive at the laboratory between 7-9 am having fasted since 10 pm the night before. The participants will be required to rest for 10 minutes, after which a measure of their blood pressure will be obtained. Participants will then be provided with breakfast (a bowl of porridge) and 140 ml concentrated nitrate-rich (\ 12.5 mmol nitrate) or nitrate-depleted beetroot juice (\ 0 mmol nitrate). Participants will then be asked to sit in the laboratory for 2.5 hours, during which time they can read quietly or use a computer. The investigators will then obtain a further measure of their blood pressure and collect a blood sample from a vein in their arm via venepuncture, to measure markers of nitric oxide, a signalling molecule in the body which is thought to mediate the blood pressure lowering effects of nitrate-rich beetroot juice.

Interventions

DIETARY_SUPPLEMENTBeet It Sport Shot

Acute supplementation with 140 ml Beet It Sport Shots, James White Ltd, containing \ 400mg dietary nitrate

DIETARY_SUPPLEMENTBeet It Sport Shot Placebo

Acute supplementation with 140 ml Beet It Sport Shots Placebo, James White Ltd, in which the nitrate has been removed via an ion exchange resin, containing \ 0 mg dietary nitrate

Sponsors

University of the West of Scotland
CollaboratorOTHER
University of Nottingham
CollaboratorOTHER
Aspire Academy
CollaboratorOTHER_GOV
Liverpool John Moores University
CollaboratorOTHER
Newcastle University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Supplements will be administered double blind (participant and researcher blind) in identical bottles. They will be identical in smell, taste, texture and colour.

Intervention model description

Replicated cross-over trial

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male volunteers * Aged 18 - 45 years

Exclusion criteria

* Aged less than 18 or more than 45 years old * Female * Currently taking any medication or antibiotics * Attending general practitioner for a health problem or on a hospital waiting list * Currently taking part in another research study which could conflict with the requirements for this investigation * Regularly use antibacterial mouthwash and unwilling to stop using this throughout the study period * Current smoker * History of kidney, liver or cardiovascular disease * Have diabetes * Have a gastrointestinal disorder * Recent history (past 1 year) of cancer * Use of other dietary supplements e.g., pre and probiotics * Currently dieting * Have a known allergy to any components within the dietary supplement

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure of the brachial arteryImmediately prior to supplementation and for 2.5 hours after supplementationBlood pressure of the brachial artery

Secondary

MeasureTime frameDescription
Plasma nitrite concentrations2.5 hours after supplementationPlasma nitrite concentrations

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026